Efavirenz as a potential drug for the treatment of triple-negative breast cancers
- P. T. Chiou
- , S. Ohms
- , P. G. Board
- , J. E. Dahlstrom
- , D. Rangasamy
- , M. G. Casarotto*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
15
Citations
(Scopus)